163 related articles for article (PubMed ID: 17189397)
1. Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas.
Nicholas MK; Lukas RV; Jafri NF; Faoro L; Salgia R
Clin Cancer Res; 2006 Dec; 12(24):7261-70. PubMed ID: 17189397
[TBL] [Abstract][Full Text] [Related]
2. The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered.
Gan HK; Cvrljevic AN; Johns TG
FEBS J; 2013 Nov; 280(21):5350-70. PubMed ID: 23777544
[TBL] [Abstract][Full Text] [Related]
3. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory Effects of Urolithins, Bioactive Gut Metabolites from Natural Polyphenols, against Glioblastoma Progression.
Shen CK; Huang BR; Charoensaensuk V; Yang LY; Tsai CF; Liu YS; Lai SW; Lu DY; Yeh WL; Lin C
Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068712
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced MRI radiomics model predicts epidermal growth factor receptor amplification in glioblastoma, IDH-wildtype.
Sohn B; Park K; Ahn SS; Park YW; Choi SH; Kang SG; Kim SH; Chang JH; Lee SK
J Neurooncol; 2023 Sep; 164(2):341-351. PubMed ID: 37689596
[TBL] [Abstract][Full Text] [Related]
6. A new paradigm for epidermal growth factor receptor expression exists in PTC and NIFTP regulated by microRNAs.
Al-Abdallah A; Jahanbani I; Ali RH; Al-Brahim N; Prasanth J; Al-Shammary B; Al-Bader M
Front Oncol; 2023; 13():1080008. PubMed ID: 37114127
[TBL] [Abstract][Full Text] [Related]
7. Pan-cancer molecular analysis of EGFR large fragment deletion in the Asian population.
Pu J; Guo H; Yu R; Ou Q; Bao H; Wu X; Tang S; Chang Q
Cancer Med; 2023 Apr; 12(7):8083-8088. PubMed ID: 36622089
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and Prognostic Value of pH- and Oxygen-Sensitive Magnetic Resonance Imaging in Glioma: A Retrospective Study.
Yao J; Hagiwara A; Oughourlian TC; Wang C; Raymond C; Pope WB; Salamon N; Lai A; Ji M; Nghiemphu PL; Liau LM; Cloughesy TF; Ellingson BM
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626127
[TBL] [Abstract][Full Text] [Related]
9. O-GlcNAcylation regulates epidermal growth factor receptor intracellular trafficking and signaling.
Wu L; Cheng Y; Geng D; Fan Z; Lin B; Zhu Q; Li J; Qin W; Yi W
Proc Natl Acad Sci U S A; 2022 Mar; 119(10):e2107453119. PubMed ID: 35239437
[TBL] [Abstract][Full Text] [Related]
10. Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma.
Barzegar Behrooz A; Talaie Z; Jusheghani F; Łos MJ; Klonisch T; Ghavami S
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163279
[TBL] [Abstract][Full Text] [Related]
11. The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein.
Lucas LM; Dwivedi V; Senfeld JI; Cullum RL; Mill CP; Piazza JT; Bryant IN; Cook LJ; Miller ST; Lott JH; Kelley CM; Knerr EL; Markham JA; Kaufmann DP; Jacobi MA; Shen J; Riese DJ
Pharmacol Rev; 2022 Jan; 74(1):18-47. PubMed ID: 34987087
[TBL] [Abstract][Full Text] [Related]
12. Targeting Glioblastoma Stem Cells: A Review on Biomarkers, Signal Pathways and Targeted Therapy.
Tang X; Zuo C; Fang P; Liu G; Qiu Y; Huang Y; Tang R
Front Oncol; 2021; 11():701291. PubMed ID: 34307170
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform.
Tang X; Xu P; Chen A; Deng G; Zhang S; Gao L; Dai L; Chen Q
Front Genet; 2020; 11():514363. PubMed ID: 33244317
[TBL] [Abstract][Full Text] [Related]
14. Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma.
Ahir BK; Engelhard HH; Lakka SS
Mol Neurobiol; 2020 May; 57(5):2461-2478. PubMed ID: 32152825
[TBL] [Abstract][Full Text] [Related]
15. Theranostic Nanomedicine for Malignant Gliomas.
d'Angelo M; Castelli V; Benedetti E; Antonosante A; Catanesi M; Dominguez-Benot R; Pitari G; Ippoliti R; Cimini A
Front Bioeng Biotechnol; 2019; 7():325. PubMed ID: 31799246
[TBL] [Abstract][Full Text] [Related]
16. Distinct Tumor Microenvironment at Tumor Edge as a Result of Astrocyte Activation Is Associated With Therapeutic Resistance for Brain Tumor.
Lin CM; Yu CF; Huang HY; Chen FH; Hong JH; Chiang CS
Front Oncol; 2019; 9():307. PubMed ID: 31106146
[TBL] [Abstract][Full Text] [Related]
17. Advances in Targeting the Epidermal Growth Factor Receptor Pathway by Synthetic Products and Its Regulation by Epigenetic Modulators As a Therapy for Glioblastoma.
Nadeem Abbas M; Kausar S; Wang F; Zhao Y; Cui H
Cells; 2019 Apr; 8(4):. PubMed ID: 31013819
[TBL] [Abstract][Full Text] [Related]
18. Glutamate Receptors and Glioblastoma Multiforme: An Old "Route" for New Perspectives.
Corsi L; Mescola A; Alessandrini A
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30978987
[TBL] [Abstract][Full Text] [Related]
19. Receptor tyrosine kinase-Ras-PI 3 kinase-Akt signaling network in glioblastoma multiforme.
Tuncel G; Kalkan R
Med Oncol; 2018 Aug; 35(9):122. PubMed ID: 30078108
[TBL] [Abstract][Full Text] [Related]
20. A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors.
Endersby R; Whitehouse J; Hii H; Greenall SA; Johns TG; Gottardo NG
Neoplasia; 2018 May; 20(5):432-442. PubMed ID: 29574250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
